Method of using CD100 (or Sema4D) to mediate platelet activation and inflammatory responses

摘要

This invention relates to methods of treating platelet disorders and/or endothelial cell disorders by modulating sema4D/CD100 activity. Specifically, this invention involves the use of compounds to increase or decrease the level of soluble sema4D/CD100.